Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain
about
Neurotrophic factors in Alzheimer’s disease: role of axonal transportAmyloid Beta annular protofibrils in cell processes and synapses accumulate with aging and Alzheimer-associated genetic modificationStructural classification of toxic amyloid oligomersDendritic and axonal mechanisms of Ca2+ elevation impair BDNF transport in Aβ oligomer-treated hippocampal neuronsSpatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice.Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding.Amyloid-beta peptide binds to microtubule-associated protein 1B (MAP1B).Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.Soluble and mature amyloid fibrils in drusen depositsEffect of synthetic aβ peptide oligomers and fluorinated solvents on Kv1.3 channel properties and membrane conductance.Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity.Alzheimer's disease and the aging brain.Solid-state NMR studies of amyloid fibril structureSoluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's diseaseRapamycin, Autophagy, and Alzheimer's DiseaseBeta amyloid oligomers and fibrils stimulate differential activation of primary microgliaNo consistent bioenergetic defects in presynaptic nerve terminals isolated from mouse models of Alzheimer's diseaseThe role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.Relevance of transgenic mouse models to human Alzheimer disease.Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.Amyloid β-protein oligomers and Alzheimer's disease.Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer's disease.P/Q-type calcium channel modulators.Animal models of Alzheimer disease.GSK-3β, a pivotal kinase in Alzheimer disease.Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.Small angle X-ray scattering analysis of Cu(2+)-induced oligomers of the Alzheimer's amyloid β peptide.Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons.Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice BrainsTwo distinct conformations of Abeta aggregates on the surface of living PC12 cells.APP/Aβ structural diversity and Alzheimer's disease pathogenesis.Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers.Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens.Inhibition of familial cerebral amyloid angiopathy mutant amyloid beta-protein fibril assembly by myelin basic protein.ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures.Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function.Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers.β-Amyloid peptide is internalized into chick retinal neurons and alters the distribution of myosin Vb.The combination of silver techniques for studying the pathology of Alzheimer's disease.
P2860
Q22242329-4AEE7511-CC36-4206-8D03-29E4D573D71DQ30157432-E1675EB6-7AB5-446F-9A4B-5CABDB28DA63Q30484255-CE9BEC97-1EB0-4D58-9ED4-4FBB3841FB6EQ30627148-9C7FF16D-C431-461A-BB58-998E72A065F9Q33263907-AA515CC9-60E6-4D59-90D8-B2DFB540D80DQ33283469-5BAB77A8-88D5-4C82-9B9C-E0746A025551Q33310236-C0900AD4-ED65-4FEC-96F5-1278D15DEB4DQ33674631-670F6F21-74E2-4C74-ABB6-211C50EE2649Q33735695-FD2BA67B-9C9D-42AC-87BB-050057033891Q34259659-34C23079-1FE3-47BC-83B6-C53A94E2196DQ34536960-0A4B73A7-7CD3-41D1-AAF7-CB6F761E0B27Q34552927-658CC280-E742-4111-9B11-AFC55B998D1CQ35327629-415BE4A0-5EBF-49BB-9F55-66976D2CA64FQ35643397-B1777F07-BEB9-4478-9086-4C0C1FC686AAQ36971857-0DA65390-3AAD-40F7-B7C6-6CB737579075Q37077638-57ABDE91-FEB8-4D46-BADB-77938145379BQ37078497-AB29F984-9DCC-4FD0-85E8-9D6A5FAD6F8AQ37211751-CE5BB21D-A138-4816-8CE2-793800B7D5DAQ37307236-01D0D621-AA7C-4F6D-B249-794814222E18Q37519545-52559958-3075-4D23-A943-94E50D36AF50Q37690332-C1D37886-31D5-4F6D-AF4E-7ECC825914BAQ37698330-0C90CD01-1861-451C-951E-2EDA13F5135FQ38012858-33B6BF2A-9273-4EBA-9C47-18B9C1E4B38EQ38016449-C0EA7E61-6CA4-4793-8BFF-9E29F40890AAQ38045853-CBA7BED9-7ED4-40B6-8C8C-ECEA0396B71AQ38218085-66A8D53A-451F-4C9A-A410-3B2649F6809AQ38938961-CA0E6A6D-153B-42CB-ABAE-5617E0B32A33Q41424638-9A621A76-9B22-4F3F-88BE-94ACB5FA3E7DQ41437626-8B2661E5-46EA-4B56-A336-E4C184F24EC7Q41653816-810D41CA-84C2-4B1F-8F19-05A034C337DBQ42065112-1A5E73D7-3E48-42FC-A43C-9F5EA1CA6513Q46320596-D9ABD1BB-0FBA-4119-A8A4-A9EFAC39B7CBQ46765690-53A73FC5-13C4-46D5-A131-2FBF8B95CA2DQ48131098-25B4CAF5-2769-4BBB-94F7-F4BD180F2EFFQ48295366-EF250769-43C4-4114-925E-F400A03D4F4BQ48530200-490FC23D-A0A5-4DDE-8D7C-702A25883367Q48569616-E4E3CC23-49B1-44D4-9D74-A8DD78EA70F2Q48654859-12DF2078-BD58-4739-92E6-C4C638DCB4DFQ52620488-89F1AED4-50FB-4F1E-9F08-0AC544CD38F4Q53291682-F593C186-8694-43EC-910E-658E7AA77156
P2860
Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Soluble Abeta oligomers ultras ...... n in Alzheimer's disease brain
@ast
Soluble Abeta oligomers ultras ...... n in Alzheimer's disease brain
@en
Soluble Abeta oligomers ultras ...... n in Alzheimer's disease brain
@nl
type
label
Soluble Abeta oligomers ultras ...... n in Alzheimer's disease brain
@ast
Soluble Abeta oligomers ultras ...... n in Alzheimer's disease brain
@en
Soluble Abeta oligomers ultras ...... n in Alzheimer's disease brain
@nl
prefLabel
Soluble Abeta oligomers ultras ...... n in Alzheimer's disease brain
@ast
Soluble Abeta oligomers ultras ...... n in Alzheimer's disease brain
@en
Soluble Abeta oligomers ultras ...... n in Alzheimer's disease brain
@nl
P2093
P1433
P1476
Soluble Abeta oligomers ultras ...... n in Alzheimer's disease brain
@en
P2093
Charles G Glabe
Haruyasu Yamaguchi
Hideko Kokubo
Rakez Kayed
P356
10.1016/J.BRAINRES.2004.10.041
P407
P577
2005-01-21T00:00:00Z